1. Home
  2. ISTR vs BBOT Comparison

ISTR vs BBOT Comparison

Compare ISTR & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Investar Holding Corporation

ISTR

Investar Holding Corporation

N/A

Current Price

$27.08

Market Cap

380.1M

Sector

Finance

ML Signal

N/A

Logo BridgeBio Oncology Therapeutics Inc.

BBOT

BridgeBio Oncology Therapeutics Inc.

N/A

Current Price

$1.87

Market Cap

442.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ISTR
BBOT
Founded
2006
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
380.1M
442.6M
IPO Year
2014
2024

Fundamental Metrics

Financial Performance
Metric
ISTR
BBOT
Price
$27.08
$1.87
Analyst Decision
Buy
Strong Buy
Analyst Count
3
12
Target Price
★ $33.58
$20.91
AVG Volume (30 Days)
61.2K
★ 630.0K
Earning Date
10-22-2026
11-10-2026
Dividend Yield
★ 1.76%
N/A
EPS Growth
4.41
★ 99.93
EPS
★ 2.11
N/A
Revenue
N/A
N/A
Revenue This Year
$62.26
N/A
Revenue Next Year
$4.82
N/A
P/E Ratio
$12.93
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.52
$1.85
52 Week High
$31.27
$14.87

Technical Indicators

Market Signals
Indicator
ISTR
BBOT
Relative Strength Index (RSI) 35.13 31.58
Support Level $26.47 N/A
Resistance Level $29.06 $2.81
Average True Range (ATR) 0.63 0.26
MACD -0.04 0.04
Stochastic Oscillator 13.89 11.80

Price Performance

Historical Comparison
ISTR
BBOT

About ISTR Investar Holding Corporation

Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashier's checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.

About BBOT BridgeBio Oncology Therapeutics Inc.

BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.

Share on Social Networks: